Breast cancer: The good, the bad, and an important call to effective risk reduction strategies
CA: A Cancer Journal for Clinicians · 2024-11 · 74 (6) · 471-474
DOI: 10.3322/caac.21867 ↗Kurz gefasst
Editorial in der Zeitschrift CA: A Cancer Journal for Clinicians, 2024-10. Verfasst von Virginia G Kaklamani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Susan G. Komen, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
- Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, Texas, USA.
ORCID-Profile: Virginia G Kaklamani
Förderung
- NCI NIH HHS
- Susan G. Komen
- Cancer Prevention and Research Institute of Texas
- Breast Cancer Research Foundation
Zitieren
APA
Kaklamani, V. G., & Arteaga, C. L. (2024). Breast cancer: The good, the bad, and an important call to effective risk reduction strategies. CA: A Cancer Journal for Clinicians, 74(6), 471-474. https://doi.org/10.3322/caac.21867
Vancouver
Kaklamani VG, Arteaga CL. Breast cancer: The good, the bad, and an important call to effective risk reduction strategies. CA: A Cancer Journal for Clinicians. 2024;74(6):471-474. doi:10.3322/caac.21867
BibTeX
@article{Kaklamani2024,
author = {Kaklamani, Virginia G and Arteaga, Carlos L},
title = {Breast cancer: The good, the bad, and an important call to effective risk reduction strategies},
journal = {CA: A Cancer Journal for Clinicians},
year = {2024},
volume = {74},
number = {6},
pages = {471--474},
doi = {10.3322/caac.21867}
}
EUVIMED